Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Mainga M HamalubaSamuel SangBenedict OrindiIrene NjauHenry K KaranjaNaomi KamauJohn N GitongaDaisy MugoDaniel WrightJames NyagwangeBernadette KutimaDonwilliams O OmuoyoMwaganyuma MwatasaCaroline J NgetsaCharles N AgotiStanley CheruiyotNyaguara O AmekMarianne MuneneNeema MturiElizaphan OlooLynette Ochola-OyierNoni MumbaCynthia MaunchoRoselyne NamayiAlun M DaviesBenjamin TsofaEunice W NduatiNadia AliyanKadondi KaseraAnthony EtyangAmy BoydAdrian HillSarah GilbertAlexander DouglasAndrew J PollardPhilip BejonTeresa LambeGeorge M Warimwenull nullPublished in: Wellcome open research (2023)
PACTR202005681895696 (11/05/2020).